Welcome to Fierce Pharma's regulatory tracker for the first half of 2025. On this page, we're recording the regulatory progress of in-market products, including expansions into key geographies and ...

Patients with a common heart rhythm disorder who took an experimental blood-thinning drug had far fewer bleeding episodes than patients receiving a standard-of-care blood thinner, a new study has ...

Ozempic, which the US Food and Drug Administration has approved ... arthritis and heart failure — such as Eliquis, Xarelto, Farxiga, Januvia, Stelara and Entresto. “For too long, big drug ...

Our share in the U.S. [NBRx] (ph) is roughly 75% and we know that with Xarelto out of the market ... ongoing study looking at taking Cobenfy with food that will read out this year.

Xarelto is a brand name of the drug rivaroxaban. Medicare covers the cost of prescription medications, including Xarelto, under certain conditions. A person must be enrolled in a Medicare Part D ...